Involvement of microRNA-135a-5p in the Protective Effects of Hydrogen Sulfide Against Parkinson's Disease

Cellular Physiology and Biochemistry

Volumn 40, Issue 1-2, 2016, Pages 18-26

  Liu, Yuanyuan ^a   Liao, Shengtao ^b,c   Quan, Hongyu ^c   Lin, Yuhan ^a   Li, Jian ^a   Yang, Qingshan ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

H 2 S; miR 135a 5p; Parkinson's disease; ROCK2

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; HYDROGEN SULFIDE; MESSENGER RNA; MICRORNA; MICRORNA 135A 5P; RHO KINASE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; APOMORPHINE; DOPAMINE; MIRN135 MICRORNA, HUMAN; MIRN135 MICRORNA, MOUSE; PROTECTIVE AGENT; ROCK2 PROTEIN, MOUSE;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; GENETIC TRANSFECTION; LUCIFERASE ASSAY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; UPREGULATION; ANIMAL; ANIMAL BEHAVIOR; BIOLOGICAL MODEL; C57BL MOUSE; CELL LINE; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; NEOSTRIATUM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROTEIN SYNTHESIS; ROTATION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 3' UNTRANSLATED REGIONS; ANIMALS; APOMORPHINE; ASTROCYTES; BASE SEQUENCE; BEHAVIOR, ANIMAL; CELL LINE; DOPAMINE; HUMANS; HYDROGEN SULFIDE; MALE; MICE, INBRED C57BL; MICRORNAS; MODELS, BIOLOGICAL; NEOSTRIATUM; PARKINSON DISEASE; PROTECTIVE AGENTS; PROTEIN BIOSYNTHESIS; RHO-ASSOCIATED KINASES; RNA, MESSENGER; ROTATION;

EID: 84995780117     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000452521     Document Type: Article

References (39)

1. Cakmak YO: Provotella-derived hydrogen sulfide, constipation, and neuroprotection in parkinson's disease. Mov Disord 2015;30:1151.
2. Hong CT, Chau KY, Schapira AH: Meclizine-induced enhanced glycolysis is neuroprotective in parkinson disease cell models. Sci Rep 2016;6:25344.
3. Siddiqui IJ, Pervaiz N, Abbasi AA: The parkinson disease gene snca: Evolutionary and structural insights with pathological implication. Sci Rep 2016;6:24475.
4. Sun Z, Jia D, Shi Y, Hou X, Yang X, Guo J, Li N, Wang J, Sun Q, Zhang H, Lei L, Shen L, Yan X, Xia K, Jiang H, Tang B: Prediction of orthostatic hypotension in multiple system atrophy and parkinson disease. Sci Rep 2016;6:21649.
5. Dearborn JT, Harmon SK, Fowler SC, O'Malley KL, Taylor GT, Sands MS, Wozniak DF: Comprehensive functional characterization of murine infantile batten disease including parkinson-like behavior and dopaminergic markers. Sci Rep 2015;5:12752.
6. Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF: Gastrointestinal dysfunction in parkinson's disease. Lancet Neurol 2015;14:625-639.
7. Kalia LV, Lang AE: Parkinson's disease. Lancet 2015;386:896-912.
8. Pagonabarraga J, Kulisevsky J, Strafella AP, Krack P: Apathy in parkinson's disease: Clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol 2015;14:518-531.
9. Wang ES, Zhang XP, Yao HB, Wang G, Chen SW, Gao WW, Yao HJ, Sun YR, Xi CH, Ji YD: Tetranectin knockout mice develop features of parkinson disease. Cell Physiol Biochem 2014;34:277-287.
10. Lee M, Tazzari V, Giustarini D, Rossi R, Sparatore A, Del Soldato P, McGeer E, McGeer PL: Effects of hydrogen sulfide-releasing l-dopa derivatives on glial activation: Potential for treating parkinson disease. J Biol Chem 2010;285:17318-17328.
11. Xue X, Bian JS: Neuroprotective effects of hydrogen sulfide in parkinson's disease animal models: Methods and protocols. Methods Enzymol 2015;554:169-186.
12. Hu LF, Lu M, Tiong CX, Dawe GS, Hu G, Bian JS: Neuroprotective effects of hydrogen sulfide on parkinson's disease rat models. Aging cell 2010;9:135-146.
13. Lu M, Zhao FF, Tang JJ, Su CJ, Fan Y, Ding JH, Bian JS, Hu G: The neuroprotection of hydrogen sulfide against mptp-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than atp-sensitive potassium channels. Antioxid Redox Signal 2012;17:849-859.
14. Liu H, Mao P, Wang J, Wang T, Xie CH: Allicin protects pc12 cells against 6-ohda-induced oxidative stress and mitochondrial dysfunction via regulating mitochondrial dynamics. Cell Physiol Biochem 2015;36:966-979.
15. Lim MS, Chang MY, Kim SM, Yi SH, Suh-Kim H, Jung SJ, Kim MJ, Kim JH, Lee YS, Lee SY, Kim DW, Lee SH, Park CH: Generation of dopamine neurons from rodent fibroblasts through the expandable neural precursor cell stage. J Biol Chem 2015;290:17401-17414.
16. Xu Y, Lu S: Regulation of beta-catenin-mediated esophageal cancer growth and invasion by mir-214. Am J Transl Res 2015;7:2316-2325.
17. Bao H, Gao F, Xie G, Liu Z: Angiotensin-converting enzyme 2 inhibits apoptosis of pulmonary endothelial cells during acute lung injury through suppressing mir-4262. Cell Physiol Biochem 2015;37:759-767.
18. Chang Y, Zhao Y, Gu W, Cao Y, Wang S, Pang J, Shi Y: Bufalin inhibits the differentiation and proliferation of cancer stem cells derived from primary osteosarcoma cells through mir-148a. Cell Physiol Biochem 2015;36:1186-1196.
19. Gao Q, Yao X, Zheng J: Mir-323 inhibits prostate cancer vascularization through adiponectin receptor. Cell Physiol Biochem 2015;36:1491-1498.
20. Ji D, Li B, Shao Q, Li F, Li Z, Chen G: Mir-22 suppresses bmp7 in the development of cirrhosis. Cell Physiol Biochem 2015;36:1026-1036.
21. Liu Z, Wang C, Wang X, Xu S: Therapeutic effects of transplantation of as-mir-937-expressing mesenchymal stem cells in murine model of alzheimer's disease. Cell Physiol Biochem 2015;37:321-330.
22. Niu X, Liu S, Jia L, Chen J: Role of mir-3619-5p in beta-catenin-mediated non-small cell lung cancer growth and invasion. Cell Physiol Biochem 2015;37:1527-1536.
23. Song N, Liu H, Ma X, Zhang S: Placental growth factor promotes metastases of ovarian cancer through mir-543-regulated mmp7. Cell Physiol Biochem 2015;37:1104-1112.
24. Song W, Li Q, Wang L, Wang L: Modulation of foxo1 expression by mir-21 to promote growth of pancreatic ductal adenocarcinoma. Cell Physiol Biochem 2015;35:184-190.
25. Yan N, Yu S, Zhang H, Hou T: Lumbar disc degeneration is facilitated by mir-100-mediated fgfr3 suppression. Cell Physiol Biochem 2015;36:2229-2236.
26. Zhang T, Tian F, Wang J, Jing J, Zhou SS, Chen YD: Endothelial cell autophagy in atherosclerosis is regulated by mir-30-mediated translational control of atg6. Cell Physiol Biochem 2015;37:1369-1378.
27. Zhang T, Tian F, Wang J, Jing J, Zhou SS, Chen YD: Atherosclerosis-associated endothelial cell apoptosis by mir-429-mediated down regulation of bcl-2. Cell Physiol Biochem 2015;37:1421-1430.
28. Zhu P, Zhang J, Zhu J, Shi J, Zhu Q, Gao Y: Mir-429 induces gastric carcinoma cell apoptosis through bcl-2. Cell Physiol Biochem 2015;37:1572-1580.
29. Xie Q, Wang Z, Zhou H, Yu Z, Huang Y, Sun H, Bi X, Wang Y, Shi W, Gu P, Fan X: The role of mir-135-modified adipose-derived mesenchymal stem cells in bone regeneration. Biomaterials 2016;75:279-294.
30. Li D, Deng T, Li H, Li Y: Mir-143 and mir-135 inhibitors treatment induces skeletal myogenic differentiation of human adult dental pulp stem cells. Arch Oral Biol 2015;60:1613-1617.
31. Ren JW, Li ZJ, Tu C: Mir-135 post-transcriptionally regulates foxo1 expression and promotes cell proliferation in human malignant melanoma cells. Int J Clin Exp Pathol 2015;8:6356-6366.
32. Yang X, Wang X, Nie F, Liu T, Yu X, Wang H, Li Q, Peng R, Mao Z, Zhou Q, Li G: Mir-135 family members mediate podocyte injury through the activation of wnt/beta-catenin signaling. Int J Mol Med 2015;36:669-677.
33. Taipaleenmaki H, Browne G, Akech J, Zustin J, van Wijnen AJ, Stein JL, Hesse E, Stein GS, Lian JB: Targeting of runx2 by mir-135 and mir-203 impairs progression of breast cancer and metastatic bone disease. Cancer Res 2015;75:1433-1444.
34. Hu Z, Yu D, Gu QH, Yang Y, Tu K, Zhu J, Li Z: Mir-191 and mir-135 are required for long-lasting spine remodelling associated with synaptic long-term depression. Nat Commun 2014;5:3263.
35. Golubovskaya VM, Sumbler B, Ho B, Yemma M, Cance WG: Mir-138 and mir-135 directly target focal adhesion kinase, inhibit cell invasion, and increase sensitivity to chemotherapy in cancer cells. Anticancer Agents Med Chem 2014;14:18-28.
36. Nagel R, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A, Meijer GA, Agami R: Regulation of the adenomatous polyposis coli gene by the mir-135 family in colorectal cancer. Cancer Res 2008;68:5795-5802.
37. Nakashima A: Proteasomal degradation of tyrosine hydroxylase and neurodegeneration. J Neurochem 2012;120:199-201.
38. Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM: Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway. J Neurosci Res 2004;76:539-550.
39. Zhou X, Cao Y, Ao G, Hu L, Liu H, Wu J, Wang X, Jin M, Zheng S, Zhen X, Alkayed NJ, Jia J, Cheng J: Camkkbeta-dependent activation of amp-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation. Antioxid Redox Signal 2014;21:1741-1758.